Lung cancer, immune thrombocytopenia and the lupus inhibitor
about
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.'Primary', 'secondary' and other variants of the antiphospholipid syndrome.Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancyRecurrent thrombosis and anticardiolipin antibodies associated with adenocarcinoma of the lung.
P2860
Lung cancer, immune thrombocytopenia and the lupus inhibitor
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Lung cancer, immune thrombocytopenia and the lupus inhibitor
@ast
Lung cancer, immune thrombocytopenia and the lupus inhibitor
@en
type
label
Lung cancer, immune thrombocytopenia and the lupus inhibitor
@ast
Lung cancer, immune thrombocytopenia and the lupus inhibitor
@en
prefLabel
Lung cancer, immune thrombocytopenia and the lupus inhibitor
@ast
Lung cancer, immune thrombocytopenia and the lupus inhibitor
@en
P2093
P2860
P356
P1476
Lung cancer, immune thrombocytopenia and the lupus inhibitor
@en
P2093
Johnson MJ
Kozlowski CL
P2860
P304
P356
10.1136/PGMJ.63.743.793
P407
P577
1987-09-01T00:00:00Z